Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Moderna Stock Surged Today

TheMotleyFool

0 0

Why Moderna Stock Surged TodayPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Shares of Moderna (NASDAQ: MRNA) jumped 7% on Monday after the biotech released positive data from a key clinical trial for its COVID-19 vaccine, mRNA-1273.

Moderna said interim data from a phase 2/3 study suggested its vaccine demonstrated "a robust neutralizing antibody response" in kids aged 6 to 11 after two 50-microgram doses. Critically, the drug also demonstrated "a favorable safety profile."

The drugmaker intends to submit the trial data to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) "in the near term."

Source Fool.com

Like: 0

MRNA

Teilen